(Report ID: 144078) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,594 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 108 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 144078 | Jun, 18, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Alkeran |
Fludarabine Phosphate |
Cyclosporine |
| Name |
Graft Versus Host Disease |
Graft Versus Host Disease In Intestine |
Graft Versus Host Disease In Skin |
Mucosal Inflammation |
Pneumonia Aspergillus |
Results from eHealthMe: 108 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Graft Versus Host Disease | 55 (50.93%) |
Graft Versus Host Disease In Intestine | 3 (2.78%) |
Graft Versus Host Disease In Skin | 14 (12.96%) |
Mucosal Inflammation | 17 (15.74%) |
Pneumonia Aspergillus | 5 (4.63%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Renal Failure | 4 (23.53%) |
2 | Interstitial Lung Disease | 3 (17.65%) |
3 | Dyspnoea | 2 (11.76%) |
4 | Cryptogenic Organising Pneumonia | 2 (11.76%) |
5 | Pleural Effusion | 2 (11.76%) |
6 | C-reactive Protein Increased | 2 (11.76%) |
7 | Cardiac Failure | 2 (11.76%) |
8 | Cardiac Failure Congestive | 2 (11.76%) |
9 | Acute Respiratory Distress Syndrome | 2 (11.76%) |
10 | Multi-organ Failure | 2 (11.76%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Neoral | 18 |
2 | Methotrexate | 16 |
3 | Unknown Drug | 15 |
4 | Sandimmune | 12 |
5 | Maxipime | 7 |
6 | Zovirax | 7 |
7 | Isotonic Sodium Chloride Solution | 7 |
8 | Urso 250 | 5 |
9 | Lidocaine | 4 |
10 | Furosemide | 4 |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Graft Versus Host Disease | 55 (50.93%) |
2 | Mucosal Inflammation | 17 (15.74%) |
3 | Graft Versus Host Disease In Skin | 14 (12.96%) |
4 | Cytomegalovirus Infection | 10 (9.26%) |
5 | Mucosal Inflammation Nos | 8 (7.41%) |
6 | Pneumonia | 7 (6.48%) |
7 | Sepsis | 7 (6.48%) |
8 | Condition Aggravated | 6 (5.56%) |
9 | Blood Bilirubin Increased | 6 (5.56%) |
10 | Multi-organ Failure | 6 (5.56%) |
| Name | Count |
1 | Methotrexate | 34 |
2 | Neoral | 20 |
3 | Acyclovir | 19 |
4 | Carmustine | 18 |
5 | Fluconazole | 16 |
6 | Sandimmune | 15 |
7 | Unknown Drug | 15 |
8 | Mini-methotrexate | 13 |
9 | Methylprednisolone | 11 |
10 | Zovirax | 11 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
